| Product NDC: | 0904-5282 |
| Proprietary Name: | RIFAMPIN |
| Non Proprietary Name: | RIFAMPIN |
| Active Ingredient(s): | 300 mg/1 & nbsp; RIFAMPIN |
| Administration Route(s): | ORAL; ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0904-5282 |
| Labeler Name: | Major Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064150 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091007 |
| Package NDC: | 0904-5282-06 |
| Package Description: | 50 CAPSULE in 1 BOX, UNIT-DOSE (0904-5282-06) |
| NDC Code | 0904-5282-06 |
| Proprietary Name | RIFAMPIN |
| Package Description | 50 CAPSULE in 1 BOX, UNIT-DOSE (0904-5282-06) |
| Product NDC | 0904-5282 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RIFAMPIN |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL; ORAL |
| Start Marketing Date | 20091007 |
| Marketing Category Name | ANDA |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | RIFAMPIN |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |